Stanford University
Stanford, California, 94304, United States
NCT Number: NCT04662554
The purpose of this study is to gain initial experience imaging HNC patient using a new PET camera, a 1mm spacial resolution. The goal is to understand image quality of the system and to see how it works in a clinical environment.
Trial opening soon.
Get Notified19 year and older
All sexes
Interventional
Not applicable
Stanford, California, 94304, United States
PRIMARY OBJECTIVE(S): Gain initial experience imaging head/neck cancer patients using a novel PET camera comprising two opposing panels with 1 millimeter spatial resolution.
SECONDARY OBJECTIVE(S):
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1-Millimeter Resolution Clinical PET System in Head and Neck Cancer (HNC) Imaging
Time frame: Day 1
PET images of HNC patients with the 1 mm resolution PET imaging device will be qualitatively accessed whether the camera can visualize the primary lesion, including heterogeneity and lymph nodes will be assessed.
Time frame: Day 1
Image quality of the 1 mm resolution PET imaging device (scale 1-5) with 5 being highest 'image quality' will be assessed to understand radioactive dose and scan time required for a given desired image quality.
Contact information is provided by the study sponsor or research team.
Stanford University
Other
Pilot Study of a 1-Millimeter Resolution Clinical PET System in Head and Neck Cancer Imaging
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07667400
Adenocarcinoma, Adenoid Cystic Carcinoma
Bethesda, Maryland, United States
View Trial DetailsNCT07630168
Bronchial Neoplasms, Carcinoma
Chapel Hill, North Carolina, United States
View Trial DetailsNCT07241273
Carcinoma, Carcinoma, Squamous Cell
Brest, France
View Trial DetailsNCT07690631
Head and Neck Cancer, Head and Neck Neoplasms
View Trial Details